1. Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial
- Author
-
Kerry L. Lee, George Sopko, Torsten Doenst, Christopher Adlbrecht, Mark C. Petrie, Serenella Castelvecchio, Lilin She, Philip F. Binkley, Rafal Dabrowski, Dominika Szalewska, Eric J. Velazquez, Myron A. Waclawiw, Robert E. Michler, Jean L. Rouleau, Ru San Tan, Jae K. Oh, Michael R. MacDonald, and Alan B. Miller
- Subjects
medicine.medical_specialty ,Ejection fraction ,business.industry ,Hazard ratio ,Stroke volume ,medicine.disease ,Confidence interval ,surgical procedures, operative ,Internal medicine ,Diabetes mellitus ,Heart failure ,medicine ,Cardiology ,cardiovascular diseases ,Cardiology and Cardiovascular Medicine ,Prospective cohort study ,business ,Surgical treatment - Abstract
The characteristics and clinical outcomes of patients with and without DM randomized to CABG and MED or MED alone were compared. DM was present in 40%. At baseline, patients with DM had more triple vessel CAD, higher LVEF, and smaller left ventricular volumes. In patients with DM, the primary outcome of all-cause mortality occurred in 39% of patients in the MED group and 39% in the CABG group [hazard ratio (HR) with CABG 0.96, 95% confidence interval (CI) 0.73–1.26]. In patients without DM, the primary outcome occurred in 41% of patients in the MED group and 32% in the CABG group (HR with CABG 0.80, 95% CI 0.63–1.02). While numerically it would appear that the treatment effect of CABG is blunted in patients with DM, there was no significant interaction between DM and treatment group on formal statistical testing.
- Published
- 2015
- Full Text
- View/download PDF